INPLASY202220059

Efficacy and safety of PARP inhibitor therapy in advanced ovarian cancer: A systematic review and network meta-analysis of randomized controlled trials

Keywords: PARP inhibitors; Olaparib; Rucaparib; Niraparib; Veliparib; ovarian cancer; systematic review; network meta-analysis.

Review Status: Ongoing